The European Academy of Dermatology and Venereology (EADV) Congress 2025, held at the Paris Convention Centre from 17 to 20 September, is set to be a powerhouse of innovation, clinical insight, and scientific exchange. With over 180 sessions, 600+ speakers, and attendees, this year’s program offers a unique opportunity to stay ahead of scientific developments, treatment innovations, and emerging trends of skin health.
Here are the top sessions you should not miss:
Emerging technologies and procedures
📅 Wednesday, 17 September
Led by MD, PhD James G. Krueger and Prof. Johann Bauer, this update session highlights the latest advances in regenerative and precision dermatology. Expect insights into promising tools like stem cells and exosomes for skin repair, targeted cellular therapies for autoimmune skin conditions, and innovative approaches using multi-specific antibodies and cell engagers to enhance immune response and treatment outcomes.
Playing with AI in Dermatology
📅 Thursday, 18 September
This interactive workshop explores how artificial intelligence (AI) is reshaping dermatological diagnostics and patient care. Chaired by Prof. Alexander Navarini, Dr. Philipp Tschandl, and Prof. Harald Kittler, the session offers a deep dive into real-world applications, and future possibilities of AI in dermatology.
Pediatric Dermatology
📅 Thursday, 18 September
This update session focuses on the unique challenges and evolving strategies in treating pediatric skin conditions. Chaired by Prof. Cristina Has and Dr. Martin Theiler, it offers insights into emerging therapies and nuanced approaches tailored to young patients. The session highlights the importance of precision and in the difficulties managing dermatological issues in children.
Atopic Dermatitis (AD)
📅 Thursday, 18 September
This update session highlights the evolving treatment of AD, driven by Chaired by Prof. Emma Guttman-Yassky and Prof. Matthias Schmuth, it bridges research with clinical practice, offering practical insights into patient-centered care.
Top Advances in 2025 Presented by ESDR
📅 Friday, 19 September
Curated by the European Society for Dermatological Research (ESDR), presents a high-level overview of recent advances across key dermatological indications. Chaired by Assoc. Prof. Beatrice Dyring-Andersen and Prof. Dr. Knut Schäkel, it highlights impactful developments in areas such as genodermatoses, psoriasis, hidradenitis suppurativa (HS), and more.
Topics in Dermatology Selected by the EADV President
📅 Friday, 19 September
This update session presents a curated selection of key dermatological themes chosen by the Prof. Branka Marinovic reflecting the strategic priorities of the Academy’s leadership. Chaired by Prof. Marinovic, Prof. Marie-Aleth Richard, and Prof. Dr. Martin Röcken, it blends clinical relevance with forward-thinking perspectives.
New and Emerging Treatment Technologies
📅 Friday, 19 September
This training and education session highlights cutting-edge innovations poised to redefine dermatological care including multi-specific antibodies & cell engagers, cell and gene therapies as well as peptides and small molecules. Chaired by Prof. Dr. Lluís Puig and Dr. Su Lwin, it offers valuable insights into emerging treatment technologies and evolving therapeutic pipelines.
Skin Microbiome
📅 Friday, 19 September
Chaired by Prof. Brigitte Dréno and Prof. Dr. Tilo Biedermann, this update session explores the evolving role of the skin microbiome in dermatology. Topics include practical approaches to measuring the microbiome in patients, its impact on conditions like acne and HS, microbiome transplantation for AD, and the use of pre-, pro-, and postbiotics to modulate skin health.
Chronic Prurigo
📅 Saturday, 20 September
This update session focuses on chronic prurigo. Chaired by Prof. Sonja Ständer and Prof. Gil Yosipovitch, the session explores the underlying pathophysiology and emerging biologic therapies.
About the Author
Audrey Fortier, M.Sc. is the Director of Scientific Affairs at Indero, where she leads clinical strategy in dermatology. With nearly 20 years of experience in clinical research, she brings extensive expertise in protocol development, regulatory compliance, and therapeutic innovation.
